Retaglutide is a novel GLP-1 receptor agonist currently under study for the management of obesity. This medication works by stimulating the effects of glucagon-like peptide-1 (GLP-1), a naturally occurring hormone that https://harmonyzanw483340.shotblogs.com/retaglutide-a-promising-glp-1-receptor-agonist-52968295